Last reviewed · How we verify
Fecal microbial transplant
At a glance
| Generic name | Fecal microbial transplant |
|---|---|
| Also known as | FMT, FMT Capsules |
| Sponsor | Western University, Canada |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
- Diarrhoea
- Abdominal pain
- Nausea
- Abdominal distension
- Urinary tract infection
- Constipation
- Flatulence
- Vomiting
- Upper respiratory tract infection
- Viral upper respiratory tract infection
- Depression
Key clinical trials
- Fecal Microbial Transplants for the Treatment of Pancreatic Cancer (EARLY_PHASE1)
- Neurocognitive Effects of FMT in MDD Patients With and Without IBS (PHASE2, PHASE3)
- Fecal Microbiota Transplantation Intervention on Microbiota Composition and Insulin Sensitivity in Diabetes (NA)
- Feasibility Study of MET-4: Evaluating Fecal Microbiome Effects in Immunotherapy Patients (PHASE2, PHASE3)
- Clostridioides Difficile: Understanding Responses and Treatment Effects
- Aging Resilience Through Microbiota Optimization and Regulation (PHASE1)
- Fecal Microbiota Transplantation for the Treatment of ICU Delirium (NA)
- Protective Effect of Probacine Against Negative Gut Metabolism and Organ Dysfunction After Cardiovascular Surgery (PANDA IV) (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |